Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2004-10-29
2009-08-25
Qian, Celine X (Department: 1636)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100, C536S024100
Reexamination Certificate
active
07579327
ABSTRACT:
An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
REFERENCES:
patent: 4866042 (1989-09-01), Neuwelt
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 5635385 (1997-06-01), Leopold et al.
patent: 5686281 (1997-11-01), Roberts
patent: 5734039 (1998-03-01), Calabretta et al.
patent: 5747340 (1998-05-01), Harats et al.
patent: 5792453 (1998-08-01), Hammond et al.
patent: 5830880 (1998-11-01), Sedlacek et al.
patent: 5906827 (1999-05-01), Khouri et al.
patent: 5916763 (1999-06-01), Williams et al.
patent: 6027743 (2000-02-01), Khouri et al.
patent: 6110480 (2000-08-01), Chu et al.
patent: 6180355 (2001-01-01), Alexander et al.
patent: 6183737 (2001-02-01), Zaleske et al.
patent: 6200751 (2001-03-01), Gu et al.
patent: 6206917 (2001-03-01), Williams et al.
patent: 6239151 (2001-05-01), Broadhurst et al.
patent: 6265216 (2001-07-01), Bennett et al.
patent: 6300127 (2001-10-01), Hair et al.
patent: 6300490 (2001-10-01), Huber et al.
patent: 6376244 (2002-04-01), Atala
patent: 6438802 (2002-08-01), Beeman et al.
patent: 6444803 (2002-09-01), Hair et al.
patent: 6479064 (2002-11-01), Atala
patent: 6497725 (2002-12-01), Williams et al.
patent: 6521750 (2003-02-01), Hair et al.
patent: 6576265 (2003-06-01), Spievack
patent: 6579697 (2003-06-01), Wallach et al.
patent: 6627189 (2003-09-01), Roth et al.
patent: 6652583 (2003-11-01), Hopkins et al.
patent: 6783776 (2004-08-01), Spievack
patent: 7067649 (2006-06-01), Harats
patent: 2003/0124100 (2003-07-01), Harats
patent: 2004/0048280 (2004-03-01), Harats
patent: 2004/0197860 (2004-10-01), Harats et al.
patent: 2004/0224389 (2004-11-01), Bellgrau et al.
patent: 2005/0186179 (2005-08-01), Harats et al.
patent: 2006/0204478 (2006-09-01), Harats et al.
patent: 2007/0286845 (2007-12-01), Harats et al.
patent: WO 98/00013 (1998-01-01), None
patent: WO 98/37901 (1998-09-01), None
patent: WO 00/06759 (2000-02-01), None
patent: WO 02/40629 (2002-05-01), None
patent: WO 03/033514 (2003-04-01), None
patent: WO 2003/093409 (2003-11-01), None
patent: WO 2004/113497 (2004-12-01), None
patent: WO 2006/051545 (2006-05-01), None
patent: WO 2007/096882 (2007-08-01), None
Garlanda, C. and Dejana, E. Heterogeneity of Endothelial Cells, Arteriosclerosis, Thrombosis, and Vascular Biology 17:1193-1202, 1997.
Faries, P.L. et al. Assessing the Role of Gene Therapy in the Treatment of Vascular Disease, Annals of Vascular Surgery 14(2):181-188, 2000.
Khan, T.A. et al. Gene Therapy Progress and Prospects: Therapeutic Angiogenesis for Limb and Myocardial Ischemia, Gene Therapy 10:285-291, 2003.
Epstein, S.E. et al. Therapeutic Interventions for Enhancing Collateral Development by Administration of Growth Factors: Basic Principles, Early Results and Potential Hazards, Cardiovascular Research 49:532-542, 2001.
Bobek, V. et al. Gene Therapy of the Ischemic Lower Limb—Therapeutic Angiogenesis, Vascular Pharmacology 44:395-405, 2006.
Barcelos et al. (Journal of Leukocyte Biology, 2005, vol. 78, pp. 352-358).
Hoefer et al. (Circulation 2002, vol. 105, pp. 1639-1641).
Whitaker et al. Society for Neuroscience Abstract Viewer and Itinerary Planner, 2003vol. 2003, pp. Abstract No. 789.12.
Aird et al. “Human von Willebrand Factor Gene Sequences Target Expression to A Subpopulation of Endothelial Cells in Transgenic Mice”, Proc. Natl. Acad. Sci. USA, 92: 4567-4571, 1995.
Aoki et al. “In Vivo Transfer Efficiency of Antisense Oligonucleotides Into the Myocardium Using Hvj-Liposome Method”, Biochemical and Biophysical Research Communications, 231: 540-545, 1997.
Araki et al. “Ninjurin2, a Novel Homophilic Adhesion Molecule, Is Expressed in Mature Sensory and Enteric Neurons and Promotes Neurite Outgrowth”, The Journal of Neuroscience, 20(1): 187-195, 2000.
Arap et al. “Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in
Ausprunk et al. “Migration and Proliferation of Endothelial Cells in Preformed and Newly Formed Blood Vessels During Tumor Angiogenesis”, Microvascular Research, 14: 53-65, 1977.
Biological Chemistry, 270(14): 7795-7798, 1995.
Brown et al. “Neovascularisation and Its Role in the Osteoarthritic Process”, Annals of the Rheumatic Diseases, 47: 881-885, 1988.
Bu et al. “Identification of an Endothelial Cell-Specific Regulatory Region in the Murine Endothelin-1 Gene”, Journal of Biological Chemistry, 272(51): 32613-32622, 1997.
Carmeliet et al. “Growing Better Blood Vessels”, Nature Biotechnology, 19: 1019-1020, 2001.
Chen et al. “Upstream Stimulatory Factors Regulate Aortic Preferentially Expressed Gene-1 Expression in Vascular Smooth Muscle Cells”, the Journal of Biological Chemistry, 276(50): 47658-47663, 2001.
Cho et al. “Development of An Efficient Endothelial Cell Specific Vector Using Promoter and 5' Untranslated Sequences From the Human Proproendothelin-1 Gene”, Experimental and Molecular Medicine, 35(4): 269-274, 2003.
Collins et al. “Molecular Cloning of the Human Gene for Von Willebrand Factor and Identification of the Transcription Initiation Site”, Proc. Natl. Acad. Sci. USA, 84: 4393-4397, 1987.
Collins et al. “Strucutre and Chromosomal Location of the Gene for Endothelial-Leukocyte Adhesion Molecule 1”, The Journal of Biological Chemistry, 266(4): 2466-2473, 1991.
Dor et al. “Induction of Vascular Networks in Adult Organs: Implications to Proangiogenic Therapy”, Annals of the NY Academy of Sciences, 995: 208-216, 2003.
Edelberg et al. “Platelet-Derived Growth Factor-AB Limits the Extent of Myocardial Infarction in A Rat Model: Feasibility of Restoring Impaired Angiogenic Capacity in the Aging Heart”, Circulation, 105: 608-613, 2002.
Feldman et al. “Progress in Antiangiogenic Gene Therapy of Cancer”, Cancer, 89: 1181-1194, 2000.
Folkman et al. “How Is Blood Vessel Growth Regulated in Normal and Neoplastic Tissue? - G.H.A. Clowes Memorial Award Lecture”, Cancer Research, 46: 467- 473, 1986.
Goldman et al. “Influence of Pressure on Permeability of Normal and Diseased Muscular Arteries to Horseradish Peroxidase. A New Catheter Approach”, Atherosclerosis, 65: 215-225, 1987.
Gorski et al. “Potentiation of the Antitumor Effect of Ionizing Radiation by Brief Concomitant Exposures to Angiostatin”, Cancer Research, 58: 5686-5689, 1998.
Greenberger et al. “Transcription-Controlled Gene Therapy Against Tumor Angiogenesis”, The Journal of Clinical Investigations, 113(7): 1017-1024, 2004.
Gu et al. “HTERT Promoter Induces Tumor-Specific Bax Gene Expression and Cell Killing in Syngenic Mouse Tumor Model and Prevents Systemic Toxicity”, Gene Therapy, 9: 30-37, 2002.
Harada et al. “Basic Fibroblast Growth Factor Improves Myocardial Function in Chronically Ischemic Porcine Hearts”, Journal of Clinical Investigation, 94: 623- 630, 1994.
Harats et al. “Targeting Gene Expression to the Vascular Wall in Transgenic Mice Using the Murine Preproendothelin-1 Promoter”, Journal of Clinical Investigation, 95(3): 1335-1344, 1995, p. 1336, Fig. 1.
Iris et al. “Dense Alu Clustering and A Potential New Member of the NFkB Family Within a 90 Kilobase HLA Class III Segment”, Nature Genetics, 3: 137-145, 1993.
Jäger et al. “Endothelial Cell-Specific Transcriptional Targeting From a Hybrid Long Terminal Repeat Retrovirus Vector Containing Human Prepro-Endothelin-1 Promoter Sequences ”, Journal of Virology, 73(12): 9702-9709, 1999.
Jones et al. “A Portable Regulatory Element Directs Specific Expression of the Caenorhabditis Elegans Ubiquitin Gene UBQ-2 in the Somatic Gonad”, Developmental Biology, 171: 60-72, 1995.
Joshi et al. “Endothelial Cells Adhere to the RGD Domain and the Fibrinogen
Bloom Nira
Breitbart Eyal
Harats Dror
Qian Celine X
Vascular Biogenics Ltd.
LandOfFree
Promoters exhibiting endothelial cell specificity and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Promoters exhibiting endothelial cell specificity and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promoters exhibiting endothelial cell specificity and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4126939